ArticleJAMA2021

Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs and Disease Flare in Patients With Rheumatoid Arthritis.

Kenneth Frank Baker et al.PubMed ↗Publisher ↗

No numbers read from the abstract.